Marko Popovic

149 posts

Marko Popovic

Marko Popovic

@PopovicMM

Retina Specialist @unityhealthTO, Medical Retina Fellowship @ucla, Ophthalmology Residency @uoftpgme, MPH @HarvardChanSPH, MD @uoftmedicine, BHSc @MacHealthSci

Toronto, Canada Katılım Aralık 2020
250 Takip Edilen356 Takipçiler
Marko Popovic retweetledi
Temerty Medicine
Temerty Medicine@uoftmedicine·
#TemertyMed study finds patients with diabetes-related eye disease who are male, Black or Hispanic, or live farther away are more likely to miss follow-up, raising risk of vision loss. bit.ly/47s5w7M
Temerty Medicine tweet media
English
6
4
7
2K
Marko Popovic retweetledi
Retina
Retina@RetinaJournal·
LARGE RETINAL CAPILLARY ANEURYSM A Delphi Consensus Study and Updated Nomenclature for a Signature Optical Coherence Tomography Lesion Popovic, Marko M. MD, MPH; et. al. Retina 45(8):p 1451-1459, August 2025 journals.lww.com/retinajournal/… #retina @PopovicMM
Retina tweet media
English
1
4
5
589
Marko Popovic retweetledi
JAMA Ophthalmology
JAMA Ophthalmology@JAMAOphth·
Most viewed this week from @JAMAophth: More than twice as many patients with diabetes exposed to glucagon-like peptide-1 receptor agonists developed neovascular age-related macular degeneration compared with matched controls. ja.ma/45M5KWS
JAMA Ophthalmology tweet media
English
0
5
11
1.4K
Marko Popovic
Marko Popovic@PopovicMM·
@davidasinclair Thank you @davidasinclair for featuring our study. We encourage further research to investigate the exact mechanisms involved. We must be vigilant of these potential risks. Patients on GLP-1 receptor agonists with new vision symptoms should be seen by an ophthalmologist.
English
0
0
0
79
Marko Popovic retweetledi
David Sinclair
David Sinclair@davidasinclair·
NEW STUDY: More than twice as many diabetic patients exposed to GLP-1 RAs (Ozempic, Wagovy, Mounjaro) developed age-related macular degeneration tinyurl.com/5a29nfh5
David Sinclair tweet media
English
116
447
2.3K
690.6K
Marko Popovic
Marko Popovic@PopovicMM·
@EricTopol Thank you @EricTopol for featuring our study. We encourage further research in this area to investigate the exact mechanisms involved. We must be vigilant of these potential risks. Patients on GLP-1 receptor agonists with new vision symptoms should be seen by an ophthalmologist.
English
0
1
6
695
Marko Popovic retweetledi
JAMA Ophthalmology
JAMA Ophthalmology@JAMAOphth·
More than twice as many patients with diabetes exposed to glucagon-like peptide-1 receptor agonists developed neovascular age-related macular degeneration compared with matched controls. ja.ma/4jARiny
JAMA Ophthalmology tweet media
English
2
5
10
1.3K
Marko Popovic retweetledi
Ophthalmology
Ophthalmology@AAOjournal·
Infants receiving ranibizumab more likely to require re-treatment but had lower refractive error, with no significant difference in complication rates compared to infants who received laser photocoagulation (GRADE: moderate-low). ow.ly/XMvx50USqZk @a_baiad7 @popovicMM
English
0
3
12
1K
Marko Popovic retweetledi
JAMA Ophthalmology
JAMA Ophthalmology@JAMAOphth·
While most ophthalmology journals have adopted guidelines on generative artificial intelligence (GenAI), this study found variability in their scope and comprehensiveness. ja.ma/3EMq0vH
JAMA Ophthalmology tweet media
English
0
6
21
1.6K